

Prescription Only Medicine — Medical Assessment Required
Skinoren 20% Cream is a topical cream containing azelaic acid 20%. It is available on prescription only in the United Kingdom and is indicated for the treatment of acne and rosacea.
Azelaic acid 20% is indicated for the treatment of mild to moderate acne and rosacea. It acts by reducing excess keratin production, inhibiting the growth of acne-causing bacteria, and reducing inflammation. It also inhibits melanin production, which may help reduce post-inflammatory hyperpigmentation associated with acne. The appropriate indication and treatment plan will be determined by your prescriber following medical assessment.
Use as directed by your prescriber. Apply a thin layer to the affected areas twice daily (morning and evening) on clean, dry skin. Gently massage into the skin until fully absorbed. Follow with a non-comedogenic moisturiser and apply a broad-spectrum SPF during the day.
Do not use on broken or irritated skin. Avoid contact with eyes, mouth, and mucous membranes. Improvement may take 4–12 weeks of consistent use.
Includes benzoic acid (preservative), cetostearyl alcohol, glycerol, and purified water, among others. For a full list, refer to the patient information leaflet supplied with your medication.
Azelaic acid is a dicarboxylic acid that acts on acne-causing bacteria, reduces inflammation, normalises skin cell turnover, and inhibits melanin production. It is used in the treatment of acne and rosacea.
Skinoren 20% Cream is a prescription-only medicine in the UK. A medical assessment is required prior to prescription approval.
Treatment duration is determined by your prescriber. Improvements in acne may be observed within 4–8 weeks of consistent use. Changes to post-inflammatory pigmentation may take longer.
Your prescriber will advise on combining Skinoren with other treatments as part of your individual treatment plan.
Yes — azelaic acid is indicated for rosacea as well as acne. Your prescriber will confirm suitability following medical assessment.
Consult your prescriber or GP before using Skinoren during pregnancy or breastfeeding. They will advise on whether it is appropriate for your individual circumstances.
No. Requesting this treatment does not guarantee that it will be prescribed. Your prescriber will determine the appropriate treatment following medical assessment.
If the treatment is not considered clinically appropriate following assessment, your prescriber will advise on alternative options.
This is a prescription-only medicine and requires medical assessment prior to prescription approval. Treatment will only be prescribed where clinically appropriate. Requesting this treatment does not guarantee that it will be prescribed. Your prescriber will determine the appropriate treatment following assessment.